[1]
“In silico identification of natural Alzheimer inhibitors targeting GSK-3β using receptor-based pharmacophore and molecular modeling studies”, IJPDD, vol. 2, no. 5, pp. 102–107, May 2025, doi: 10.62896/ijpdd.2.5.11.